(Q50480530)

English

Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers

scientific article published in April 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

bioavailability

1 reference

based on heuristic

inferred from title

author name string

Klem B

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

Lappin G

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

Nicholson S

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

van de Wetering J

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

de Vries DE

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

Oosterhuis B

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

Garner RC

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

46

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

456-460

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

Current understanding of the biology of advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Bladder cancer: epidemiology, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist!

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Fluorescence cystoscopy and bladder surveillance

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Current perspectives of 14 C-isotope measurement in biomedical accelerator mass spectrometry

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer

1 reference

https://api.crossref.org/works/10.1177%2F0091270006286849

21 January 2018

Identifiers

10.1177/0091270006286849

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

release_eh3lqbqv7zf2xp4js7g6g2paru

1 reference

https://api.fatcat.wiki/v0/release/eh3lqbqv7zf2xp4js7g6g2paru

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/16554454

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50480530&oldid=2250824737"